“Great science, great technology, great thinking, and great connectivity can change the world,” said Charles J. Ryan, MD, CEO of the Prostate Cancer Foundation, as he welcomed the world’s leading experts in prostate cancer care to the inaugural PSMA Conference, held at University of California, San Francisco, January 18-19, 2024.
More than 500 attendees in-person and online explored the current and future use of PSMA (prostate-specific membrane antigen) PET imaging and PSMA radioligand therapy to improve the clinical care of patients with prostate cancer, the most common cancer among men in the United States. Attendees included leading cancer physicians, nuclear medicine imaging specialists and technologists, and researchers from world-renown cancer centers. The conference was co-sponsored by UCSF and the University of California, Los Angeles, with support from the…
